Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 233

1.

Analysis of von hippel-lindau mutations with comparative genomic hybridization in sporadic and hereditary hemangioblastomas: possible genetic heterogeneity.

Gijtenbeek JM, Jacobs B, Sprenger SH, Eleveld MJ, van Kessel AG, Kros JM, Sciot R, van Calenbergh F, Wesseling P, Jeuken JW.

J Neurosurg. 2002 Oct;97(4):977-82.

PMID:
12405390
2.

Characteristic chromosomal aberrations in sporadic cerebellar hemangioblastomas revealed by comparative genomic hybridization.

Sprenger SH, Gijtenbeek JM, Wesseling P, Sciot R, van Calenbergh F, Lammens M, Jeuken JW.

J Neurooncol. 2001 May;52(3):241-7.

PMID:
11519854
3.

Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system.

Gläsker S, Bender BU, Apel TW, van Velthoven V, Mulligan LM, Zentner J, Neumann HP.

J Neurol Neurosurg Psychiatry. 2001 May;70(5):644-8.

5.

Molecular genetic analysis of the von Hippel-Lindau disease tumor suppressor gene in familial and sporadic cerebellar hemangioblastomas.

Tse JY, Wong JH, Lo KW, Poon WS, Huang DP, Ng HK.

Am J Clin Pathol. 1997 Apr;107(4):459-66.

PMID:
9124215
6.

Meningioma showing VHL gene inactivation in a patient with von Hippel-Lindau disease.

Kanno H, Yamamoto I, Yoshida M, Kitamura H.

Neurology. 2003 Apr 8;60(7):1197-9.

PMID:
12682336
7.

Loss of heterozygosity at 6q is frequent and concurrent with 3p loss in sporadic and familial capillary hemangioblastomas.

Lemeta S, Pylkkänen L, Sainio M, Niemelä M, Saarikoski S, Husgafvel-Pursiainen K, Böhling T.

J Neuropathol Exp Neurol. 2004 Oct;63(10):1072-9.

PMID:
15535134
8.

Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas.

Lee JY, Dong SM, Park WS, Yoo NJ, Kim CS, Jang JJ, Chi JG, Zbar B, Lubensky IA, Linehan WM, Vortmeyer AO, Zhuang Z.

Cancer Res. 1998 Feb 1;58(3):504-8.

9.

Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma.

Olschwang S, Richard S, Boisson C, Giraud S, Laurent-Puig P, Resche F, Thomas G.

Hum Mutat. 1998;12(6):424-30.

PMID:
9829912
11.

Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas.

Kanno H, Kondo K, Ito S, Yamamoto I, Fujii S, Torigoe S, Sakai N, Hosaka M, Shuin T, Yao M.

Cancer Res. 1994 Sep 15;54(18):4845-7.

12.

Von Hippel-Lindau disease germline mutations in Mexican patients with cerebellar hemangioblastoma.

Rasmussen A, Nava-Salazar S, Yescas P, Alonso E, Revuelta R, Ortiz I, Canizales-Quinteros S, Tusié-Luna MT, López-López M.

J Neurosurg. 2006 Mar;104(3):389-94.

PMID:
16572651
13.

Differences in genetic and epigenetic alterations between von Hippel-Lindau disease-related and sporadic hemangioblastomas of the central nervous system.

Takayanagi S, Mukasa A, Tanaka S, Nomura M, Omata M, Yanagisawa S, Yamamoto S, Ichimura K, Nakatomi H, Ueki K, Aburatani H, Saito N.

Neuro Oncol. 2017 Sep 1;19(9):1228-1236. doi: 10.1093/neuonc/nox034.

PMID:
28379443
14.

Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors.

Prowse AH, Webster AR, Richards FM, Richard S, Olschwang S, Resche F, Affara NA, Maher ER.

Am J Hum Genet. 1997 Apr;60(4):765-71.

15.
16.

Von Hippel-Lindau syndrome. A pleomorphic condition.

Friedrich CA.

Cancer. 1999 Dec 1;86(11 Suppl):2478-82. Review.

PMID:
10630173
17.

Somatic von Hippel-Lindau gene mutations detected in sporadic endolymphatic sac tumors.

Vortmeyer AO, Huang SC, Koch CA, Governale L, Dickerman RD, McKeever PE, Oldfield EH, Zhuang Z.

Cancer Res. 2000 Nov 1;60(21):5963-5.

18.

Recurrent DNA sequence copy losses on chromosomal arm 6q in capillary hemangioblastoma.

Lemeta S, Aalto Y, Niemelä M, Jääskeläinen J, Sainio M, Kere J, Knuutila S, Böhling T.

Cancer Genet Cytogenet. 2002 Mar;133(2):174-8.

PMID:
11943349
19.

High frequency loss of heterozygosity in von Hippel-Lindau (VHL)-associated and sporadic pancreatic islet cell tumors: evidence for a stepwise mechanism for malignant conversion in VHL tumorigenesis.

Lott ST, Chandler DS, Curley SA, Foster CJ, El-Naggar A, Frazier M, Strong LC, Lovell M, Killary AM.

Cancer Res. 2002 Apr 1;62(7):1952-5.

20.

Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas.

Dannenberg H, De Krijger RR, van der Harst E, Abbou M, IJzendoorn Y, Komminoth P, Dinjens WN.

Int J Cancer. 2003 Jun 10;105(2):190-5.

Supplemental Content

Support Center